An unbiased primary sensory neuron screen identifies the chemotherapeutic agent bortezomib as a potent TRPV1 sensitizer. Such long-term sensitization could lead to axonal death and sensory loss, a major symptom of bortezomib-induced neuropathy.
- Jared M. Sprague
- Ajay S. Yekkirala
- Alban Latremoliere